KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Change in Inventory (2018 - 2025)

Adaptive Biotechnologies' Change in Inventory history spans 8 years, with the latest figure at $10000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory rose 100.3% year-over-year to $10000.0; the TTM value through Dec 2025 reached $998000.0, up 118.58%, while the annual FY2025 figure was $998000.0, 118.58% up from the prior year.
  • Change in Inventory for Q4 2025 was $10000.0 at Adaptive Biotechnologies, down from $1.3 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $6.6 million in Q1 2023 and bottomed at -$4.0 million in Q4 2023.
  • The 5-year median for Change in Inventory is -$27500.0 (2023), against an average of $142350.0.
  • The largest annual shift saw Change in Inventory surged 6511.11% in 2021 before it tumbled 721.61% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $1.0 million in 2021, then crashed by 393.51% to -$3.0 million in 2022, then tumbled by 31.3% to -$4.0 million in 2023, then increased by 14.96% to -$3.4 million in 2024, then surged by 100.3% to $10000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Change in Inventory are $10000.0 (Q4 2025), $1.3 million (Q3 2025), and -$95000.0 (Q2 2025).